|
Monetary
research
Indian pharmaceutical companies have started investing heavily
in research, especially after India became TRIPs compliant.
As the R&D budgets of various companies sky rocket, Nandini
Patwardhan looks at the way ahead.
Wockhardt
to launch Cefprozil in US
Pharmaceutical and biotechnology major Wockhardt got USFDA
approval for antibiotic Cefprozil tablets (250 mg and 500
mg) and is all set to launch the product in the US market.
Glenmark
gets tentative approval for Terbinafine
Glenmark Pharmaceuticals received tentative approval from
the USFDA for its ANDA for Terbinafine HCL 250 mg oral tablets.
Life
in the biotech lane
Over the years, Bangalore Bio has become a brand amongst numerous
biotech events. Katya Naidu reports
Upcoming
Event
'IAVI
supports a comprehensive approach to HIV'
The recent collaboration of the International AIDS Vaccine
Initiative (IAVI) with the Department of Biotechnology (Ministry
of Science and Technology, Government of India) gives re-birth
to hopes of an AIDS vaccine. Dr Sonali Kochhar, Medical Director,
IAVI, talks to Aashruti Kak about their plans to crack the
HIV virus.
Orchid
forays into non-antibiotic generics
Orchid Chemicals & Pharmaceuticals received the tentative
approval from the USFDA for its ANDA for Terbinafine HCL 250
mg Tablets.
Indoco
sets up new R&D centre
Indoco Remedies has set up a new R&D centre at Rabale,
near New Mumbai. This Rs 225 million centre is expected to
transform the company into an integrated player in CRAMS space.
Veritaz
Healthcare to unveil its brands
Veritaz Healthcare, a Hyderabad based pharmaceutical company
is launching its brands in the month of June in all Southern
and Western States of India. This will be followed by the
launch in Northern and Eastern India.
IBPL
receives EU-GMP certification
Intas Biopharmaceuticals Limited (IBPL) has achieved a unique
distinction to become India's first dedicated biopharmaceutical
company to receive certification of European Agency for the
Evaluation of Medicinal Products (EMEA) for its manufacturing
facility at Ahmedabad, Gujarat.
Strides
acquires Grandix and receives two NDA approvals
Strides has signed a definitive agreement to acquire 100 percent
of Grandix Pharmaceuticals and its subsidiary Grandix Laboratories
on a cash and debt free basis valuing 100 percent of the company
at Rs 100 crores.
Lilly
wins award for TB initiative
Eli Lilly has been recognised for conceiving and implementing
a global partnership to address the multi-drug resistant tuberculosis
pandemic.
Aptuit
to invest in Laurus Labs
Global contract drug development firm Aptuit and Hyderabad-based
Laurus Labs formed a contract drug development company, Aptuit
Laurus in India.
Pall
introduces ultrafiltration cassettes
Pall Corporation has introduced the new OmegaTM T-Series Membrane
Cassettes to offer enhanced processing efficiencies and greater
product recovery.
Welcome
to India!
Clestra Cleanroom inaugurated its new plant in Pune on 12th
June. The ceremony was graced with the presence of Dominique
Girard, French Ambassador to India, along with Jean-Luc Buckard,
Chairman, Clestra Cleanroom, and Thierry Gefffroy, Managing
Director, Clestra Cleanroom. "It is a great pleasure
to be at the inauguration of Clestra and it feels great to
applaud the efforts of a French medium-sized company,"
said Girard.
|
